glp 1 chronic kidney disease New Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs Glucagon-Like Peptide-1 Receptor Agonists for

Gastroenterology 143, 765776.e3

In addition to treating diabetes and obesity, these medications have cardiovascular benefits, and theres evidence they may curb addiction and possibly even protect against some types of cancer, which has only further broadened their appeal

However, a major shift occurred in November 2025 when the Trump administration negotiated MFN pricing deals with Novo Nordisk and Eli Lilly, reducing Medicare/Medicaid prices for Ozempic, Wegovy, Zepbound, and Mounjaro to approximately $245/month , with Medicare beneficiary co-pays of $50/month ( [17] ) ( [22] )

Exenatide-induced acute pancreatitis

from the University of the District of Columbia, David A